ALETHEA CAPITAL MANAGEMENT, LLC RNA Holdings History
ALETHEA CAPITAL MANAGEMENT, LLC's Avidity Biosciences Inc Holding Summary
As of 2025-03-31, ALETHEA CAPITAL MANAGEMENT, LLC held 421,724.00 shares of Avidity Biosciences Inc(RNA), totaling $12.45 Mil. This investment constitutes 9.29% of their stock portfolio, and ALETHEA CAPITAL MANAGEMENT, LLC now holds 0.35% of the outstanding Avidity Biosciences Inc(RNA) stock.
The initial trade took place in 2020Q4. And since then ALETHEA CAPITAL MANAGEMENT, LLC has made 5 purchases of RNA, at an average price of $29.00, for a total of 1.60 Mil shares. In addition, there have been 10 sales at an average price of $24.64 for 1.18 Mil shares. Based on historical transaction data and RNA's current price of $29.17, ALETHEA CAPITAL MANAGEMENT, LLC's estimated gain on his RNA holdings is $-5.06 Mil, reflecting a -10.91% gain to date.
ALETHEA CAPITAL MANAGEMENT, LLC RNA ($29.17) Holding Chart
ALETHEA CAPITAL MANAGEMENT, LLC RNA ($29.17) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1